1. Sanna G, Bertolaccini ML, Cuadrado MJ, Khamashta MA, Hughes GR. Central nervous system involvement in the antiphospholipid (Hughes) syndrome. Rheumatology (Oxford). 2003; 42:200–13.
Article
2. Hughes GR. Heparin, antiphospholipid antibodies and the brain. Lupus. 2012; 21:1039–40.
Article
3. Cuadrado MJ, Khamashta MA, Hughes GR. Migraine and stroke in young women. QJM. 2000; 93:317–8.
Article
4. Cuadrado MJ, Khamashta MA, D'Cruz D, Hughes GR. Migraine in Hughes syndrome–heparin as a therapeutic trial? QJM. 2001; 94:114–5.
Article
5. BH H. Systemic Lupus Erythematosus. Longo DL FA, Kasper DL, Hauser SL, Jameson JL, Loscalzo J, editors. Harrison's Principles of Internal Medicine. 18th ed.New York: McGraw-Hill;2012.
6. Sanna G, D'Cruz D, Cuadrado MJ. Cerebral manifestations in the antiphospholipid (Hughes) syndrome. Rheum Dis Clin North Am. 2006; 32:465–90.
Article
7. Hughes GR, Cuadrado MJ, Khamashta MA, Sanna G. Headache and memory loss: rapid response to heparin in the antiphospholipid syndrome. Lupus. 2001; 10:778.
8. Moutsopoulos HM VP. Antiphospholipid Antibody Syndrome. Longo DL FA, Kasper DL, Hauser SL, Jameson JL, Loscalzo J, editors. Harrison's Principles of Internal Medicine. 18th ed.New York: McGraw-Hill;2012.
9. Connor P, Hunt BJ. Cerebral haemostasis and antiphospholipid antibodies. Lupus. 2003; 12:929–34.
Article
10. Katzav A, Chapman J, Shoenfeld Y. CNS dysfunction in the antiphospholipid syndrome. Lupus. 2003; 12:903–7.
Article
11. Ziporen L, Polak-Charcon S, Korczyn DA, Goldberg I, Afek A, Kopolovic J, et al. Neurological dysfunction associated with antiphospholipid syndrome: histopathological brain findings of thrombotic changes in a mouse model. Clin Dev Immunol. 2004; 11:67–75.
Article